G8929 Adjuvant chemotherapy not prescribed or previously received, reason not given

Short descriptor: Adj cmo not pres rsn not gvn

⚠ Terminated HCPCS Level II 2026
Terminated Code
G8929 was terminated as of 2016-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open G8929 in the app →

Look up G8929 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

G8929 is the HCPCS Level II code for Adjuvant chemotherapy not prescribed or previously received, reason not given (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Medical care
Effective Date
2017-01-01
Termination Date
2016-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference G8929 with the canonical source and edition:

G8929 — Adjuvant chemotherapy not prescribed or previously received, reason not given. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G8929

Canonical URL: https://icd10codingpro.com/hcpcs-codes/G8929

Related Codes in Section G

← G8928 Adj chem not pres rsn spec G8930 → Assess of dep @ initial eval
G8925 Spir fev1/fvc>=60% & no copd G8926 Spiro no perf or doc G8927 Adj chem pres ajcc iii G8928 Adj chem not pres rsn spec G8930 Assess of dep @ initial eval G8931 Asses of dep not documented G8932 Suicd rsk assessed init eval G8933 Suicide risk not assessed G8934 Lvef <=40% or dep lv sys fcn G8935 Rx ace or arb therapy
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial